Skip to Main Content
HBS Home
  • About
  • Academic Programs
  • Alumni
  • Faculty & Research
  • Baker Library
  • Giving
  • Harvard Business Review
  • Initiatives
  • News
  • Recruit
  • Map / Directions
Faculty & Research
  • Faculty
  • Research
  • Featured Topics
  • Academic Units
  • …→
  • Harvard Business School→
  • Faculty & Research→
  • Research
    • Research
    • Publications
    • Global Research Centers
    • Case Development
    • Initiatives & Projects
    • Research Services
    • Seminars & Conferences
    →
  • Publications→

Publications

Publications

Filter Results: (221) Arrow Down
Filter Results: (221) Arrow Down Arrow Up

Show Results For

  • All HBS Web  (478)
    • News  (140)
    • Research  (221)
    • Multimedia  (8)
  • Faculty Publications  (139)

Show Results For

  • All HBS Web  (478)
    • News  (140)
    • Research  (221)
    • Multimedia  (8)
  • Faculty Publications  (139)
← Page 10 of 221 Results →
Sort by

Are you looking for?

→Search All HBS Web
  • October 2012
  • Teaching Note

GlaxoSmithKline in Brazil: Public-Private Vaccine Partnerships

By: Arthur A. Daemmrich
Citation
Purchase
Related
Daemmrich, Arthur A. "GlaxoSmithKline in Brazil: Public-Private Vaccine Partnerships." Harvard Business School Teaching Note 713-044, October 2012.
  • December 2010
  • Supplement

Denmark: Globalization and the Welfare State (PPT)

By: Arthur A. Daemmrich
Citation
Purchase
Related
Daemmrich, Arthur A. "Denmark: Globalization and the Welfare State (PPT)." Harvard Business School PowerPoint Supplement 711-057, December 2010.
  • December 2010 (Revised April 2012)
  • Background Note

Stalemate at the WTO: TRIPS, Agricultural Subsidies, and the Doha Round

By: Arthur A. Daemmrich
This note analyzes disputes over intellectual property enforcement and agricultural trade barriers at the center of the Doha Round of World Trade Organization (WTO) negotiations. Fundamental principles of intellectual property rights and agricultural subsidies are... View Details
Keywords: Agribusiness; Trade; Globalization; Governance; International Relations; Intellectual Property; Agreements and Arrangements; Agriculture and Agribusiness Industry; Pharmaceutical Industry
Citation
Educators
Purchase
Related
Daemmrich, Arthur A. "Stalemate at the WTO: TRIPS, Agricultural Subsidies, and the Doha Round." Harvard Business School Background Note 711-043, December 2010. (Revised April 2012.)
  • January 2009 (Revised July 2009)
  • Case

Targanta Therapeutics: Hitting a Moving Target

By: Arthur A. Daemmrich
This case explores regulatory, product testing, and business strategy at Targanta Therapeutics, a biotech company preparing its first new drug application to the FDA. In October 2007, Mark Leuchtenberger, president and CEO of Targanta—which has just held a successful... View Details
Keywords: Decision Choices and Conditions; Entrepreneurship; Governing Rules, Regulations, and Reforms; Health Testing and Trials; Product Development; Business and Government Relations; Business Strategy; Biotechnology Industry; Pharmaceutical Industry
Citation
Educators
Purchase
Related
Daemmrich, Arthur A. "Targanta Therapeutics: Hitting a Moving Target." Harvard Business School Case 709-002, January 2009. (Revised July 2009.)
  • 2004
  • Book

R&D Meets M&A: Proceedings of the 2003 Conference on Innovation and Creativity in Chemical R&D

By: Arthur A. Daemmrich
Keywords: Research and Development; Mergers and Acquisitions; Conferences; Innovation and Invention; Creativity; Science
Citation
Read Now
Related
Daemmrich, Arthur A., ed. R&D Meets M&A: Proceedings of the 2003 Conference on Innovation and Creativity in Chemical R&D. Chemical Heritage Press, 2004.
  • January 2000
  • Article

The Tragedy of the Commoners: Biotechnology and its Publics

By: Arthur A. Daemmrich
Keywords: Biotechnology Industry
Citation
Find at Harvard
Related
Daemmrich, Arthur A. "The Tragedy of the Commoners: Biotechnology and its Publics." Nature Biotechnology 18, no. 1 (January 2000): 2–4.
  • December 2000
  • Article

Risk versus Risk: Tragic Choices in Drug Regulation in the United States and Germany

By: Arthur A. Daemmrich
Keywords: Risk and Uncertainty; Decision Choices and Conditions; Health; United States; Germany
Citation
Find at Harvard
Related
Daemmrich, Arthur A. "Risk versus Risk: Tragic Choices in Drug Regulation in the United States and Germany." Science as Culture 9, no. 4 (December 2000): 505–534.
  • fall 2002
  • Article

Science and Medicine in Court: Expert Testimony in the German Thalidomide Trial

By: Arthur A. Daemmrich
Keywords: Science; Health; Courts and Trials; Pharmaceutical Industry; Germany
Citation
Find at Harvard
Related
Daemmrich, Arthur A. "Science and Medicine in Court: Expert Testimony in the German Thalidomide Trial." Chemical Heritage, no. 20 (fall 2002): 12–13, 28–33.
  • Article

Invisible Monuments and the Costs of Pharmaceutical Regulation: Twenty-Five Years of Drug Lag Debate

By: Arthur A. Daemmrich
Keywords: Cost; Health; Governing Rules, Regulations, and Reforms; Communication
Citation
Find at Harvard
Related
Daemmrich, Arthur A. "Invisible Monuments and the Costs of Pharmaceutical Regulation: Twenty-Five Years of Drug Lag Debate." Pharmacy in History 45, no. 1 (2003): 3–17.
  • April 2011 (Revised October 2011)
  • Teaching Note

U.S. Healthcare Reform: International Perspectives (TN)

By: Arthur A. Daemmrich and Elia Cameron
Teaching Note for #710-040 and 711-103. View Details
Keywords: Health Care and Treatment; Governing Rules, Regulations, and Reforms; United States
Citation
Purchase
Related
Daemmrich, Arthur A., and Elia Cameron. "U.S. Healthcare Reform: International Perspectives (TN)." Harvard Business School Teaching Note 711-062, April 2011. (Revised October 2011.)
  • November 2010 (Revised July 2012)
  • Teaching Note

Arcadia Biosciences: Seeds of Change (TN)

By: Arthur A. Daemmrich and Forest L. Reinhardt
Teaching Note for 709019. View Details
Keywords: Biotechnology Industry
Citation
Purchase
Related
Daemmrich, Arthur A., and Forest L. Reinhardt. "Arcadia Biosciences: Seeds of Change (TN)." Harvard Business School Teaching Note 711-042, November 2010. (Revised July 2012.)
  • May 2011 (Revised December 2011)
  • Case

Stuyvesant Town - Peter Cooper Village: America's Largest Foreclosure

By: Arthur I Segel, Gregory S. Feldman, James T. Liu and Elizabeth C. Williamson
In July 2010, William Ackman, the founder of Pershing Square, is considering a potential new opportunity: the acquisition of the distressed Stuyvesant Town and Peter Cooper Village ("ST /PCV") complex. The property had recently been abandoned by its owners and had come... View Details
Keywords: Property; Risk Management; Opportunities; Valuation; Insolvency and Bankruptcy; Investment; Outcome or Result; Acquisition; North and Central America
Citation
Educators
Purchase
Related
Segel, Arthur I., Gregory S. Feldman, James T. Liu, and Elizabeth C. Williamson. "Stuyvesant Town - Peter Cooper Village: America's Largest Foreclosure." Harvard Business School Case 211-106, May 2011. (Revised December 2011.)
  • March 2011
  • Teaching Note

International Lobbying and the Dow Chemical Company (TN) (A) & (B)

By: Arthur A. Daemmrich
Teaching Note for 710027 and 710028. View Details
Keywords: Governing Rules, Regulations, and Reforms; Production; Non-Governmental Organizations; Strategy; Business and Government Relations; Government Legislation; Chemical Industry
Citation
Purchase
Related
Daemmrich, Arthur A. "International Lobbying and the Dow Chemical Company (TN) (A) & (B)." Harvard Business School Teaching Note 711-061, March 2011.
  • July 2009 (Revised June 2012)
  • Teaching Note

Denmark: Globalization and the Welfare State (TN)

By: Arthur A. Daemmrich
Teaching Note for [709015]. View Details
Keywords: Globalization; Government and Politics; Poverty; Denmark
Citation
Purchase
Related
Daemmrich, Arthur A. "Denmark: Globalization and the Welfare State (TN)." Harvard Business School Teaching Note 710-007, July 2009. (Revised June 2012.)
  • November 2008 (Revised July 2009)
  • Background Note

A Managerial Perspective on Clinical Trials

By: Arthur A. Daemmrich
This note describes the history and regulation of clinical trials, managerial challenges related to pharmaceutical product testing, and current debates regarding prescription drug safety. Since clinical testing takes between five and seven years, and consumes up to 70... View Details
Keywords: Governing Rules, Regulations, and Reforms; Health Testing and Trials; Product Development; Safety; Biotechnology Industry; Pharmaceutical Industry
Citation
Educators
Purchase
Related
Daemmrich, Arthur A. "A Managerial Perspective on Clinical Trials." Harvard Business School Background Note 709-033, November 2008. (Revised July 2009.)
  • 2003
  • Chapter

Regulatory Laws and Political Culture in the United States and Germany

By: Arthur A. Daemmrich
Keywords: Government and Politics; Governing Rules, Regulations, and Reforms; United States; Germany
Citation
Related
Daemmrich, Arthur A. "Regulatory Laws and Political Culture in the United States and Germany." In Regulation of the Pharmaceutical Industry, edited by John Abraham and Helen Lawton Smith, 11–41. Palgrave Macmillan, 2003.
  • 2003
  • Chapter

La tragédie de la thalidomide: affaires judiciaries et résponses législatives, 1959-1971

By: Arthur A. Daemmrich
Keywords: History; Courts and Trials; Government Legislation; Health Disorders; Pharmaceutical Industry
Citation
Related
Daemmrich, Arthur A. "La tragédie de la thalidomide: affaires judiciaries et résponses législatives, 1959-1971." In La médicine expérimentale au tribunal, edited by Christian Bonah, Etienne Lepicard, and Volker Roelcke, 291–318. Éditions des archives contemporaines, 2003.
  • 2006
  • Chapter

BioRisk: interleukin-2 from laboratory to market in the United States and Germany

By: Arthur A. Daemmrich
Keywords: Product Development; Risk and Uncertainty; Health Testing and Trials; Pharmaceutical Industry; Biotechnology Industry; United States; Germany
Citation
Related
Daemmrich, Arthur A. "BioRisk: interleukin-2 from laboratory to market in the United States and Germany ." In The Risks of Medical Innovation: Risk Perception and Assessment in Historical Context, edited by Thomas Schlich and Ulrich Tröhler, 242–261. Routledge, 2006.
  • August 2016
  • Teaching Note

The Role of Real Estate in Endowment Portfolios: The Case of Christ Church College

By: Arthur I. Segel and Alexander W. Schultz
The case centers on Christ Church’s Treasurer, James Lawrie, who is contemplating his options for investing a portion of the College’s endowment in real estate. Approximately 1/3 of the total $690 million endowment was allocated towards real estate, much higher than... View Details
Keywords: Portfolio Allocation; Oxford; England; Real Estate; University Endowment; Higher Education; Investment Portfolio; Property; Corporate Finance; Financial Services Industry; England
Citation
Purchase
Related
Segel, Arthur I., and Alexander W. Schultz. "The Role of Real Estate in Endowment Portfolios: The Case of Christ Church College." Harvard Business School Teaching Note 217-009, August 2016.
  • 28 Aug 2012
  • First Look

First Look: August 28

The Brazil-USA Cotton Dispute and the Incremental Balancing of Interests Author: Arthur A. Daemmrich Publication: Trade, Law and Development (summer 2012) Abstract The World Trade Organization (WTO) features... View Details
Keywords: Sean Silverthorne
  • ←
  • 10
  • 11
  • 12
  • →

Are you looking for?

→Search All HBS Web
ǁ
Campus Map
Harvard Business School
Soldiers Field
Boston, MA 02163
→Map & Directions
→More Contact Information
  • Make a Gift
  • Site Map
  • Jobs
  • Harvard University
  • Trademarks
  • Policies
  • Accessibility
  • Digital Accessibility
Copyright © President & Fellows of Harvard College.